Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) fell 2.2% on Tuesday . The stock traded as low as $2.25 and last traded at $2.25. 750 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 2,814 shares. The stock had previously closed at $2.30.
Idorsia Price Performance
The company has a 50-day simple moving average of $2.39 and a two-hundred day simple moving average of $2.16.
Idorsia Company Profile
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Featured Stories
- Five stocks we like better than Idorsia
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Sales Breakout Sends This Semiconductor Stock to Record High
- When to Sell a Stock for Profit or Loss
- Surprise Buying Opportunity on This Dividend Aristocrat
- Energy and Oil Stocks Explained
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.